Clarke, Nathan A. http://orcid.org/0000-0002-8636-1872
Wong, Brendon http://orcid.org/0000-0003-1559-3841
Lawrance, Rachael
IngelgÄrd, Anders
Griebsch, Ingolf
Cella, David
Trigg, Andrew
Article History
Received: 10 July 2023
Accepted: 1 August 2024
First Online: 15 August 2024
Declarations
:
: The trial was carried out in accordance with the principles of the Declaration of Helsinki, in accordance with the International Conference for Harmonisation clinical practice guidelines, in accordance with applicable regulatory requirements, and in compliance with the clinical trial protocol. Informed consent was obtained from each study participant.
: N/A.
: NC, and RL: are employees of Adelphi Values. Adelphi Values conducted the study analyses. Adelphi Values were paid consultants to Boehringer Ingelheim in connection with the development of this manuscript. AT was an employee at Adelphi Values at the time of this study, but is currently an employee of Bayer Plc. BW and AI are employees of Boehringer Ingelheim. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials of the study apart from those disclosed. IG was an employee at Boehringer Ingelheim at the time of this study, but is currently an employee of Ferring Arzneimittel GmbH. DC is the President of FACIT.org and was a paid consultant to Boehringer Ingelheim for this research. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.